NeuraLight just raised $25 million in its bid to create new, digital endpoints that can be used by clinicians and researchers to objectively measure neurological conditions with the ultimate goal - still several years away - to have the company's technology serve as the gold standard for neurological evaluation.
Neuralight seeks to improve the design of neurological clinical trials, increase the probability of success for novel neurological therapeutics, as part of a new era of precision medicine for neurology.
The process of diagnosing and tracking the progression of neurological disorders is often long and imprecise, involving surveys, hospital visits, and in-person observations that experts must interpret on the fly. NeuraLight claims it’s built a better way, one that uses nothing but an ordinary webcam and could have a huge effect on how these conditions […]
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.